v3.26.1
Business Combination - Purchase price allocation (Details) - Advent BioServices
$ in Thousands, £ in Millions
12 Months Ended
Oct. 24, 2025
USD ($)
Oct. 24, 2025
GBP (£)
Dec. 31, 2025
USD ($)
Business Combination      
Total Non-AP Consideration $ 1,864 £ 1.4  
Assets acquired and liabilities assumed      
Cash 359    
Current assets 355    
Fixed assets, net 909    
Intangible assets 51,518   $ 52,000
Total assets acquired 53,141    
Accrued expenses (3,905)    
Deferred tax liability (13,074)    
Total liabilities assumed (19,231)    
Net identifiable assets acquired 33,910    
Accrued liabilities forgiven 3,386    
Capital contribution $ (35,432)    
Business Combination Bargain Purchase Gain Recognized Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag true true  
Re-sale of the intangible assets $ 52,000   $ 52,000
Non Related party      
Assets acquired and liabilities assumed      
Accounts payable (1,583)    
Related party      
Assets acquired and liabilities assumed      
Accounts payable $ (669)